Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

PF-Fentanyl Citrate

GMP Deviations: potential glass contamination

Terminated cGMP deviation Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class II · Moderate risk

Rifampin for Injection

Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Terminated Impurity / degradation Mylan Laboratories Limited (Sterile Products Division) NDC 67457-445-60 D-0139-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-9 D-0299-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-8 D-0298-2020
Class II · Moderate risk

Estradiol tablets

Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol 0.5 mg Tablets.

Terminated Particulate / foreign matter Epic Pharma, LLC NDC 42806-087-01 D-0135-2020

Recalls by year